Secretion of noncomplexed 'big' (10-18 kD) forms of insulin-like growth factor-II by 12 soft tissue sarcoma cell lines

Hormone Research

Volumn 52, Issue 4, 1999, Pages 178-185

  Elmlinger, Martin W ^a   Rauschnabel, Uta ^a   Koscielniak, Ewa ^b   Weber, Karin ^a   Ranke, Michael B ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b OLGAHOSPITAL   (Germany)

Author keywords

Chromatography; Insulin like growth factor; Non islet cell tumour hypoglycaemia; Pro IGF II; Soft tissue sarcoma

Indexed keywords

MESSENGER RNA; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CELL LINE; CELL SECRETION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST CULTURE; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPOGLYCEMIA; MOLECULAR WEIGHT; PEDIATRICS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT TISSUE SARCOMA; TUMOR CELL LINE; TUMOR GROWTH;

EID: 0033494793     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023458     Document Type: Article

References (20)

1. Sussenbach JS, Steenbergh PH, Holthuizen P: Structure and expression of the human insulin-like growth factor genes. Growth Regul 1992;2: 1-9.
2. Schneid H, Le Boue Y: Insulin-like growth factor 2 and growth. Growth Genet Horm 1994; 10:1-4.
3. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endoer Rev 1995;16:3-34.
4. Wang W-H, Duan J-X, Vu TH, Hoffman AR: Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity. J Biol Chem 1996;271:27863-27870.
5. Elmlinger MW, Sanatani MS, Bell M, Dannecker G, Ranke MB: Elevated insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-4 expression of leukemic T-cells is affected by autocrinc/paracrine IGF-II action but not by IGF type I receptor expression. Eur J Endocrinol 1998;138:337-343.
6. Daughaday WH, Trivedi B: Heterogeneity of serum peptides with immunoactivity detected by a radioimmunoassay for proinsulin-like growth factors-II E domain: Description of a free E domain peptide in the serum. J Clin Endocrinol Metab 1992;75:641-645.
7. Daughaday WH, Dewell TF: Tumor secretion of growth factors. Endocrinol Metab Clin North Am 1991;20:539-563.
8. Zumstein PP, Luthi C, Humbel RE: Amino acid sequence of a variant pro-form of insulin-like growth factor II. Proc Natl Acad Sci USA 1985;83:3169-3172.
9. Daughaday WH, Wu JC, Lee SD, Kapadia M: Abnormal processing of pro-IGF-II in patients with hepatoma and in some hepatitis B virus-positive asymptomatic individuals. J Lab Clin Med 1990;116:555-562.
10. Culouscou JM, Remacle-Bonnet M, Garrouste F, Fantini J, Marvaldi J, Pommier G: Production of insulin-like growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon carcinoma cell line. J Cell Physiol 1990;143:405-415.
11. Duguay SJ, Jin Y, Stein J, Duguay AN, Gardner P, Steiner DF: Posttranslational processing of the insulin-like growth factor-2 precursor. J Biol Chem 1998;273:18443-18451.
12. Daughaday WH, Trivedi B: Measurement of derivates of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 1992;75:110-115.
13. Baxter RC: The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia. Horm Res 1996;46:195-201.
14. Schwartz GN, Hudgins WR, Perdue JF: Glycosylated insulin-like growth factors II promoted expansion of granulocyte-macrophage colony-forming cells in serum-deprived liquid cultures of human peripheral blood cells. Exp Hematol 1993;21:1447-1454.
15. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P: Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 1988;319:1434-1440.
16. Schmitt S, Ren-Qiu Q, Torresani T, Doebeli M. Zapf J, Schoenle EJ: High molecular weight forms of IGF-II ('big-IGF-II') released by Wilms' tumor cells. Eur J Endocrinol 1997; 137:396-401.
17. Elmlinger MW, Rauschnabel U, Koscielniak E, Haenze J, Ranke MB, Berthold A, Klammt J, Kiess W: Correlation of type-1 insulin-like growth factor receptor (IGF-I-R) and insulin receptor-related receptor (IRR) messenger RNA levels in tumor cell lines from pediatric tumors of neuronal origin. Regul Pept 1999;84: 37-42.
18. Daughaday WH, Trivedi B, Baxter R: Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acidlabile subunit and leads to elevation of serum-free IGF-I. Endocrine 1995;3:425-428.
19. Yang CQ, Zhan X, Hu X, Kondcpudi A, Perdue JF: The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the o-glycosylation of its E domain. Endocrinology 1996;137:2766-2773.
20. Hoeflich A, Wolf E, Braulke T, Koepf G, Kessler U, Brem G, Rascher W, Blum W, Kiess W: Does the overexpression of proinsulin-like growth factor-II in transfected human embryonic kidney fibroblasts increase the secretion of lysosomal enzymes? Eur J Biochem 1995;232:172-178.